U.K. drugmaker AstraZeneca (AZN - Get Report) agreed to buy specialty pharmaceutical company Omthera (OMTH) for $12.70 a share, or about $323 million, a premium of 88% to Omthera's closing price on Friday of $6.77. 5 Stocks Soaring on Unusual Volume
Valeant Pharmaceuticals (VRX - Get Report), Canada's largest drugmaker, announced it has agreed to acquire eye-care company Bausch & Lomb for $8.7 billion. Valeant to Buy Bausch & Lomb
-- Written by Joseph Woelfel >To contact the writer of this article, click here: Joseph Woelfel >To submit a news tip, send an email to: firstname.lastname@example.org.